×
Neuronetics Total Assets 2017-2024 | STIM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Neuronetics total assets from 2017 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
View More
Neuronetics Total Assets 2017-2024 | STIM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Neuronetics total assets from 2017 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$196.3B
Intuitive Surgical (ISRG)
$195.1B
Alcon (ALC)
$42.4B
Edwards Lifesciences (EW)
$41.6B
IQVIA Holdings (IQV)
$36.6B
IDEXX Laboratories (IDXX)
$34.2B
DexCom (DXCM)
$28.4B
Waters (WAT)
$22.2B
STERIS (STE)
$21.2B
SONOVA HOLDING (SONVY)
$20.8B
Hologic (HOLX)
$18.3B
Fresenius Medical Care AG KGaA (FMS)
$13B
Sysmex ADR (SSMXY)
$12.9B
Globus Medical (GMED)
$11.5B
Penumbra (PEN)
$9.4B
Masimo (MASI)
$9.3B
Teleflex (TFX)
$8.9B
Glaukos (GKOS)
$7.9B
PROCEPT BioRobotics (PRCT)
$4.9B
Integer Holdings (ITGR)
$4.6B
Veracyte (VCYT)
$3.1B
Inari Medical (NARI)
$2.9B
LivaNova (LIVN)
$2.8B
TransMedics (TMDX)
$2.6B
Nihon Kohden (NHNKY)
$2.5B
Elekta AB (EKTAY)
$2.2B
Tandem Diabetes Care (TNDM)
$2B
Integra LifeSciences Holdings (IART)
$1.8B
RxSight (RXST)
$1.8B
Alphatec Holdings (ATEC)
$1.4B